Clinical trial
Using Soluble ST2 to Predict Clinical Outcomes in Patients Receiving Primary Percutaneous Coronary Intervention With ST-elevation Myocardial Infarction
NCT02830217 is registered in ClinicalTrials.gov with Wuhan Asia Heart Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Using Soluble ST2 to Predict Clinical Outcomes in Patients Receiving Primary Percutaneous Coronary Intervention With ST-elevation Myocardial Infarction
- Lead sponsor
- Wuhan Asia Heart Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2015
- Completion date
- December 20, 2018
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.